Jordan Dubow, M.D., has extensive experience in the pharmaceutical and biotech industry, where he has served in full time and acting Chief Medical Officer (CMO) capacities for over 10 companies, both public and private, leading all clinical and regulatory aspects of development for small and large molecule drugs and cell and gene therapies. He has played a pivotal role in over a dozen new drug applications (NDAs) in the U.S., including Emflaza®, as well as numerous NDAs in Europe, Japan, Canada, and Australia. Dr. Dubow began his career as an academic board-certified neurologist focusing on Parkinson’s disease and vascular neurology. He completed medical school and a neurology residency at the Northwestern University Feinberg School of Medicine, a movement disorders fellowship at a Northwestern University-affiliated hospital and a vascular neurology fellowship at NewYork-Presbyterian / Weill Cornell Medical Center.